Wordt geladen...
Tackling COVID-19 with neutralizing monoclonal antibodies
Monoclonal antibodies (mAbs) have revolutionized the treatment of several human diseases, including cancer and autoimmunity and inflammatory conditions, and represent a new frontier for the treatment of infectious diseases. In the last 20 years, innovative methods have allowed the rapid isolation of...
Bewaard in:
| Gepubliceerd in: | Cell |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8152891/ https://ncbi.nlm.nih.gov/pubmed/34087172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2021.05.005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|